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INTRODUCTION
Asthma is defined as a reversible airway obstructive disease 
with increased airway hyperresponsiveness (AHR) and chronic 
airway inflammation.
1 However, irreversible airflow obstruc-
tion, which is largely caused by airway remodeling, can occur 
in some asthmatics. Histological changes that define airway re-
modeling include smooth muscle hyperplasia and hypertro-
phy, vascular proliferation, increased number of bronchial 
glands, and collagen deposition.
2–5 The avoidance of irrevers-
ible structural changes is critical in managing asthma, because 
the changes can cause partially irreversible airway obstruction 
and sustained AHR even after prolonged steroid therapy.
2 Im-
portantly, airway remodeling can begin in early childhood and 
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with mild intermittent asthma.
4,6
The most direct way of assessing airway remodeling is by his-
tological examination of lung biopsy specimens. Alternatively, 
pulmonary function testing (PFT), which is has been used in 
clinical settings and epidemiological studies, can link changes 
in mechanical properties of airways with airway remodeling. 
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Purpose:  Airway remodeling may be responsible for irreversible airway obstruction in asthma, and a low post-bronchodilator FEV1/FVC ratio can 
be used as a noninvasive marker of airway remodeling. We investigated correlations between airway wall indices on computed tomography (CT) 
and various clinical indices, including post-bronchodilator FEV1/FVC ratio, in patients with asthma.  Methods:  Volumetric CT was performed on 22 
stable asthma patients who were taking inhaled corticosteroids. Airway dimensions were measured at four segmental bronchi using in-house soft-
ware based on the full-width/half-maximum method. Parameters included luminal area, wall thickness (WT), wall thickness percentage (WT%), 
wall area percentage (WA%), bronchial-to-arterial diameter (BA) ratio on inspiration CT, airway collapsibility (AC), and air trapping index (ATI). Corre-
lations were analyzed between CT parameters and clinical indices, including %FEV1, FEV1/FVC, FEF25–75%, and post-bronchodilator FEV1/FVC ra-
tio.  Results:  Post-bronchodilator FEV1/FVC showed significant correlations with WT%, WT, BA ratio, AC, and ATI (r=–0.503, –0.576, 0.454, 0.475, 
and –0.610, respectively). WT showed negative correlations with FEV1/FVC and FEF25–75% (r=–0.431 and –0.581), and WT% was negatively correlat-
ed with %FEV1, FEV1/FVC, and FEF25–75% (r=–0.434, –0.431, and –0.540, respectively). WA% showed correlations with FEF25–75% and body mass in-
dex (r=–0.459 and 0.453). The BA ratio was positively correlated with %FEV1 (r=0.459) and FEF25–75% (r=0.479). AC showed strong positive correla-
tion with FEV1/FVC (r=0.592), and ATI showed negative correlations with FEV1/FVC (r=–0.534) and FEF25–75% (r=–0.591). Conclusions:  WT%, WT, 
BA ratio, and AC on inspiration and expiration CT are good indices for measuring airway remodeling defined by post-bronchodilator FEV1/FVC in sta-
ble asthma patients treated with inhaled corticosteroids.
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Measurement of airway wall thickening on computed tomogra-
phy (CT) is a noninvasive method for assessing structural air-
way changes. In several trials, high-resolution CT (HRCT) to as-
sess airway remodeling in asthma has provided information 
about a broad range of lung morphological features,
7–15 in a less 
invasive manner than biopsy.
16 However, with CT, a possibility 
of errors exists because measurements of airway dimensions 
are based on manual tracing. To minimize errors, the full-
width/half-maximum (FWHM) principle has recently been in-
troduced for the quantitative assessment of airway wall dimen-
sions.
17
Although PFT can be used to evaluate the degree of airflow 
obstruction, the results can be affected by concomitant diseas-
es or the short-term condition of the patient. For PFT to be ap-
plicable as a noninvasive method of assessing airway remodel-
ing, the findings must correlate with those of HRCT. A low post-
bronchodilator FEV1/FVC ratio has recently been proposed as 
a noninvasive marker of airway remodeling
4 and as evidence of 
the need for preventative inhaled corticosteroid therapy in mild 
intermittent asthma.
6 In terms of mechanical properties, airway 
wall thickening and collagen deposition can stiffen the subepi-
thelial matrix and make the airways less responsive to broncho-
dilators.
18–20 This alteration can also present as decreased dis-
tensibility during inspiration or as collapsibility during expira-
tion. Airway collapsibility (AC) during expiration can be as-
sessed by measuring the change in luminal area between inspi-
ration and expiration CT.
The purpose of our study was to investigate the usefulness of 
automatic measurements of airway dimensions on CT for the 
assessment of airway remodeling, by analyzing the relation-
ships between airway wall indices and PFT parameters. To our 
knowledge, this is the first study to analyze the correlations be-
tween airway wall indices on CT and post-bronchodilator 
FEV1/FVC, which is a known surrogate marker of airway re-
modeling, and to directly assess AC using automatic airway 
wall measurements on inspiration and expiration CT.
MATERIALS AND METHODS
Subjects
Forty-one patients experiencing dyspnea, cough, and wheez-
ing for longer than 3 months were recruited from the allergy 
clinic at Asan Medical Center. The patients were diagnosed 
with asthma according to the American Thoracic Society crite-
ria.
1 Study inclusion criteria included a baseline FEV1/FVC of 
≤80% and either demonstrated significant AHR (PC20 metha-
choline, <8 mg/mL) or significant bronchodilator responsive-
ness (>12% improvement in %FEV1 predicted after administra-
tion of 180 μg of albuterol via a metered-dose inhaler) before 
asthma treatment.
21 One patient was excluded because the CT 
scan was obtained using a different protocol, and 18 patients 
were excluded because they had smoked more than five packs 
of cigarettes throughout their lifetime. Thus, 22 patients (3 men 
and 19 women; mean age, 50.2 years; age range, 25–70 years) 
were enrolled. All participants were non-smokers or ex-smok-
ers who had smoked less than five packs throughout their life-
time. Each had received inhaled corticosteroid therapy (mainly 
250–500 µg fluticasone) for several months to years, with or 
without other asthma medication, to maintain optimal physical 
condition. All patients gave informed consent to undergo PFT 
and CT, and the study protocol was approved by the institution-
al review board of our hospital.
CT
CT was performed in patients in a stably managed state and 
without evidence of asthma exacerbation. In all patients, volu-
metric CT scans were performed at both full inspiration and ex-
piration, using a 16-channel, multidetector CT scanner (So-
matom Sensation 16; Siemens Medical Solutions, Erlangen, 
Germany) with 16×0.75-mm collimation, 100 eff. mA, and 140 
kVp. The CT dose index (approximately 22.5 mGy) was within 
the acceptable in range. The acquired data were reconstructed 
using a standard kernel (B30) with 0.75 thickness and 0.7-mm 
increments. Images were stored in the Digital Imaging and 
Communications in Medicine (DICOM) format, which is the 
international standard for connecting medical imaging devices 
on standard networks.
In-house software was used for airway measurements. Figure 
shows the overall procedure and snapshots of each stage of the 
procedure. After loading the DICOM images, the user is re-
quested to select a point in the airway lumen. The software then 
estimates the central axis of the airway lumen using a depth 
map algorithm and reconstructs an oblique image orthogonal 
to the axis. The software magnifies the oblique image 10-fold 
Figure.  Measurement of airway dimensions. This image briefly shows the 
process of measuring the airway dimensions using our in-house software. Af-
ter the selection of a segmental bronchus, the data regarding airway dimen-
sions were automatically obtained.Airway Measurement for Airway Remodeling in Asthma AAIR 
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using a bi-cubic interpolation algorithm, segments the lumen 
according to a Hounsfield unit-based thresholding technique, 
and then calculates the center of inertia of the lumen. The air-
way wall indices are determined by analysis of 120 rays cast 
around 360° from the center, according to the FWHM method.
17 
The software was validated using polyacryl tubes with various 
inner diameters and wall thicknesses.
22,23
Airway dimensions were measured at the origin of four seg-
mental bronchi: right apical bronchus, left apico-posterior 
bronchus, and the posterior basal segmental bronchus in each 
lower lobe. Measurements were made at the same anatomic lo-
cations on both inspiration and expiration CT scans. Mean val-
ues were used for each subject. To analyze luminal changes, the 
bronchial-to-arterial diameter (BA) ratio was measured on CT 
images obtained on inspiration, and the luminal area (LA) was 
measured on inspiration and expiration CT images. The mea-
sured luminal areas were used to calculate AC as [(LAinsp − 
LAexp)/LAinsp]×100. The airway wall indices included wall thick-
ness (WT), wall thickness percentage [WT%=(WT/outer diame-
ter)×100], and wall area percentage [WA%=(WA/WA+LA)×100].
Given that an increase in end-expiratory lung volume (EELV) 
caused by air trapping can influence AC, we analyzed the rela-
tionship between AC and EELV. The ratio between mean 
whole-lung density (MLD) on expiration and inspiration (ML-
Dexp/MLDinsp) was used as the air trapping index (ATI).
Clinical parameters
The clinical indices included body mass index (BMI), asthma 
severity, and spirometry data before and after use of broncho-
dilators. The severity of asthma was evaluated by physicians at 
the time of CT scanning and was classified as mild, moderate, 
or severe based primarily on the Global Initiative for Asthma 
guidelines.
24 All subjects were prohibited from using any kind 
of bronchodilators for a minimum of 6 hours before CT scan-
ning, and the time between inhaled corticosteroid use and CT 
scanning did not differ among the subjects. Pre- and post-bron-
chodilator tests were performed on the same day as CT scan-
ning, or on the day before or after. To evaluate the presence of 
atopy, skin prick testing for 11 common aeroallergens (Allergo-
pharma, Reinbek, Germany) was performed as previously de-
scribed.
25 Atopy was defined as a positive skin prick test re-
sponse (allergen/histamine ratio >1.0 plus mean wheal size >3 
mm) to one or more allergens. Testing was performed at the 
time asthma was diagnosed, irrespective of CT scanning.
Statistical analysis
The SPSS statistical package (version 12.0; Chicago, IL, USA) 
was used for statistical analysis. The relationships between air-
way wall indices measured on CT and clinical indices were 
evaluated using Spearman’s correlation test. Values of P<0.05 
were considered to indicate statistical significance.
RESULTS
The demographic characteristics and clinical indices of our 
study subjects are presented in Table 1, and the airway dimen-
sions measured in four segmental bronchi are shown in Table 2. 
There was no significant difference between airway dimensions 
in four segmental bronchi.
Table 3 lists the correlations between the CT measurements 
and clinical indices. WT% showed negative correlations with 
%FEV1, FEV1/FVC, FEF25–75%, and post-bronchodilator FEV1/
FVC (r=–0.434, P=0.043; r=–0.431, P=0.019; r=–0.540, P=0.009; 
and r=–0.503, P=0.017, respectively) and a positive correlation 
with asthma severity (r=0.470, P=0.027). WT was negatively 
correlated with FEV1/FVC, FEF25–75%, and post-bronchodilator 
FEV1/FVC (r=–0.431, P=0.045; r=–0.581, P=0.005; and r=–0.576, 
P=0.005, respectively), and WA% was negatively correlated with 
FEF25–75% (r=−0.459, P=0.032) and BMI (r=0.453, P=0.034). The 
BA ratio showed positive correlations with %FEV1, FEF25–75%, 
and post-bronchodilator FEV1/FVC (r=0.459, P=0.032; r=0.479, 
P=0.024; and r=0.454, P=0.034, respectively). AC showed a  Table 1.  Demographic characteristics and overall clinical indices
Characteristics/index Value
Age (yr) 50.23 ± 11.48
Gender, F:M (n) 19:3
Body mass index 24.65 ± 2.77
Pre-bronchodilator FEV1 (% predicted) 78.63 ± 15.62
Post-bronchodilator FEV1 (% predicted) 81.89 ± 16.30
Pre-bronchodilator FEV1/FVC (% predicted) 85.58 ± 11.01
Post-bronchodilator FEV1/FVC (% predicted) 87.23 ± 10.60
FEF25–75% (% predicted) 52.35 ± 22.63
Asthma severity, mild:moderate:severe (n) 6:9:7
Atopy, atopy:non-atopy (n)  6:11
Results are means ± SD.
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; FEF25-75%, 
forced expiratory flow between 25 and 75% FVC.
Table 2.  Airway dimensions in four segmental bronchi
Parameter RB1 LB1+2 RB10 LB10
WT 1.92 ± 0.29 2.13 ± 0.27 1.86 ± 0.25 2.06 ± 025
WT% 48.06 ± 4.49 46.07 ± 5.51 44.95 ± 9.07 47.68 ± 10.15
WA% 80.39 ± 6.22 84.03 ± 8.91 81.45 ± 8.71 86.23 ± 6.04
LAinsp 15.53 ± 9.24 24.22 ± 11.15 20.15 ± 9.89 20.59 ± 8.90
LAexp 12.74 ±10.53 16.38 ± 8.55 11.89 ± 6.99 13.19 ± 6.92
AC 0.23 ± 0.23 0.28 ± 0.27 0.35 ± 0.31 0.35 ± 0.21
RB1, apical segmental bronchus of right upper lobe; LB1+2, apico-posterior seg-
mental bronchus of left upper lobe; RB10, posterior basal segmental bronchus 
of right lower lobe; LB10, posterior basal segmental bronchus of right lower 
lobe; WT, wall thickness; WT%, wall thickness percentage; WA%, wall area 
percentage; LA, luminal area; AC, airway collapsibility.Chae et al.
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strong positive correlation with FEV1/FVC (r=0.592, P=0.004) 
and post-bronchodilator FEV1/FVC (r=0.475, P=0.025). ATI 
was negatively correlated with FEV1/FVC, FEF25–75%, and post-
bronchodilator FEV1/FVC (r=–0.534, P=0.011; r=–0.591, 
P=0.004; and r=−0.610, P=0.003, respectively). AC showed no 
significant correlation with EELV (r=−0.416, P=0.054).
DISCUSSION
We demonstrated that the WT%, WT, BA ratio, AC, and ATI 
were correlated with post-bronchodilator FEV1/FVC, which is 
a surrogate marker of airway remodeling. In practice, it is im-
portant to noninvasively assess airway remodeling during treat-
ment and follow-up of patients with asthma. Our study is be-
lieved to be the first to reveal that in addition to post-broncho-
dilator FEV1/FVC, airway wall indices on CT can be used as 
surrogate markers of airway remodeling.
Although biopsy is the most accurate method of determining 
airway remodeling, it is an invasive procedure. In children and 
young adults, the ratio of FEV1 to FVC is a useful index of the 
status of the airway.
26,27 Rasmussen et al.
4 have shown that air-
way remodeling is demonstrated by a low post-bronchodilator 
FEV1/FVC, and several studies have used low post-bronchodi-
lator FEV1/FVC as a marker of persistent airflow limitation or 
airway remodeling.
6,28 Although those studies measured post-
bronchodilator FEV1/FVC in a consecutive manner, it is 
thought that a one-time check of post-bronchodilator FEV1/
FVC reflects the real-time state of persistent airflow limitation 
in patients who have received optimal treatment to reach a sta-
ble condition. Considering the association between airway 
structural alterations and severe asthma,
5 post-bronchodilator 
FEV1/FVC may be an important marker of airway remodeling. 
In addition, pre-bronchodilator FEV1/FVC has been used as an 
indicator of global airway obstruction in asthma in several 
HRCT studies.
16,29 Our data showed significant correlations of 
asthma severity with both pre- and post-bronchodilator FEV1/
FVC.
In previous studies, the airway wall was thicker in patients 
with asthma, and greater wall thickening was associated with 
more severe asthma.
7–15,30 These studies measured the apical 
bronchus of the right upper lobe because of its tangential ori-
entation. We used the mean values of the airway dimensions of 
four segmental bronchi, presuming that these would be closer 
to the actual airway dimensions. Kasahara et al.
11 compared the 
airway dimensions, the reticular basement membrane (Rbm) 
on biopsy, and FEV1 between asthmatics and control subjects, 
showing that WA% and WT% were strongly correlated with 
Rbm thickness. These findings suggest that Rbm thickening 
parallels the airway wall thickening, which can cause irrevers-
ible airflow obstruction in asthma.
We investigated the luminal change between inspiration and 
expiration CT and defined it as AC. Brown et al.
31 used HRCT to 
test the hypothesis that when the lungs of asthmatics become 
inflated by deep inspiration, the airways do not distend; how-
ever, they found no defect in airway distensibility in patients 
with asthma, perhaps because they selected stable patients 
Table 3.  Correlations between CT measurements and clinical indices
Clinical index LA WT WT% WA% BA ratio AC ATI
Gender R 0.110 0.440
* 0.073 0.361 -0.113 0.071 -0.313
P 0.627 0.041 0.747 0.099 0.618 0.752 0.157
Age R -0.512
* -0.157 0.512
* 0.282 -0.136 -0.115 -0.219
P 0.015 0.486 0.015 0.204 0.547 0.611 0.327
BMI R -0.091 0.306 0.113 0.453
* -0.125 0.369 0.033
P 0.687 0.166 0.615 0.034 0.580 0.091 0.883
Severity R -0.229 0.361 0.470
* 0.260 -0.259 -0.150 -0.385
P 0.306 0.099 0.027 0.243 0.244 0.506 0.077
% FEV1 R 0.265 -0.333 -0.434
* -0.347 0.459
* 0.417 0.380
P 0.234 0.130 0.043 0.113 0.032 0.053 0.081
FEV1/FVC R 0.364 -0.431
* -0.495
* -0.345 0.365 0.592
† 0.534
*
P 0.096 0.045 0.019 0.116 0.095 0.004 0.011
FEF25-75% R 0.257 -0.581
† -0.540
† -0.459
* 0.479
* 0.411 0.591
†
P 0.248 0.005 0.009 0.032 0.024 0.058 0.004
Post-bronchodilator  R 0.232 -0.576
† -0.503
* -0.363 0.454
* 0.475
* 0.610
†
FEV1/FVC P 0.299 0.005 0.017 0.097 0.034 0.025 0.003
*P<0.05; 
†P<0.01.
LA, luminal area; WT, wall thickness; WT%, wall thickness percentage; WA%, wall area percentage; BA, bronchial-to-arterial diameter; AC, airway collapsibility; 
ATI, air trapping index; BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; FEF25-75%, forced expiratory flow between 25 and 
75% FVC.Airway Measurement for Airway Remodeling in Asthma AAIR 
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with mild intermittent asthma who used only sympathomimet-
ic inhalers on an as-needed basis. In our study of patients with 
asthma of various severities, AC had a strong positive correla-
tion with pre- and post-bronchodilator FEV1/FVC, indicating 
that more severe obstruction showed a lower AC. One possible 
explanation of this finding is that in at least some patients, the 
process that thickens the airways also makes them stiffer and 
less collapsible during expiration. Wilson et al.
20 have reported 
that patients with asthma exhibit less distensible airways dur-
ing inspiration, based on the change in anatomic dead space. 
Other researchers have attributed this phenomenon to Rbm 
thickening by showing an inverse correlation between anatom-
ic dead space and Rbm thickness.
19 Using an esophageal bal-
loon and a Pitot static probe to obtain area-versus-transmural 
pressure curves during forced expiration, Brackel et al.
18 also in-
dicated that asthmatic airways may be less collapsible or dis-
tensible and concluded that airway remodeling may result in 
stiffer dynamic elastic properties of the airway walls. Fibrotic 
changes induced by airway remodeling may cause airways with 
persistent airflow obstruction to become less collapsible. Alter-
natively, an increase in residual lung volume due to air trapping 
in patients with obstructive lung disease may decrease airway 
collapse during expiration. In the present study, because AC 
did not correlate with EELV, the decrease in AC is thought to re-
flect the intrinsic stiffness of the airway resulting from wall 
thickening.
In our study, ATI showed negative correlations with FEV1/
FVC, FEF25–75%, and post-bronchodilator FEV1/FVC. These re-
sults are similar to previous observations. Gono et al.
9 have re-
ported that the expiration/inspiration ratio of MLD is negative-
ly correlated with FEV1, and Mitsunobu et al.
32 have demon-
strated that MLD is lower in unstable asthmatics than in stable 
asthmatics. However, our results more accurately reflect the ac-
tual CT value because we obtained volumetric data, whereas 
others obtained data from selected levels. Carroll et al.
33 have 
reported that small airways are the predominant obstruction 
sites in postmortem studies.
34 Although changes in small air-
ways cannot be directly visualized on CT, air trapping is indi-
rectly reflected by abnormal decreases in lung attenuation.
34 In 
our study, ATI obtained by CT has been proven to be a useful 
parameter for assessing the presence of small airway obstruc-
tion.
The BA ratio showed positive correlations with FEV1, FEF25–75% 
and post-bronchodilator FEV1/FVC. The pulmonary artery di-
ameter is largely influenced by circulating volume and local hy-
poxia.
35 In general, the BA ratio increases with altitude, presum-
ably due to to hypoxic bronchodilatation and vasoconstric-
tion.
36 However, a reduced BA ratio is more common in patients 
with asthma than in control subjects.
14 This is an interesting ob-
servation considering that asthma patients exhibit a higher ex-
pression level of vascular endothelial growth factor compared 
with controls. Given that increased vascular endothelial growth 
factor is correlated with increased vascularity and angiogene-
sis,
37 it may contribute to airway wall remodeling.
The BMI showed a positive correlation with WA%. This is con-
sistent with a previously reported association between obesity 
and asthma.
38
This study is believed to be the first to use the FWHM princi-
ple for measuring airway dimensions in asthma. Since McNa-
mara et al.
39 first measured airway dimensions using HRCT in 
canine lung, investigators have sought to demonstrate the rela-
tionship between airway wall thickness and function.
7–15,30 In 
earlier studies, airway dimensions were measured by semi-
quantitative assessment using manual tracing,
15 which created 
problems when measuring small bronchi because the bound-
aries between the lumen, wall, and parenchyma became diffi-
cult to define. Forkert et al. overcame this problem by using the 
density plot of a straight line perpendicular to the airway wall.
40 
Nakano et al.
17 used the FWHM principle to measure airway di-
mensions in the lungs of smokers, and the FWHM technique 
has been demonstrated to be a reproducible method of airway 
measurement.
41
One limitation of our study is the uncertainty regarding how 
closely CT measurements reflect in vivo airway dimensions; for 
example, secretions might have caused an overestimation of 
WT. Another limitation is that the CT scans were performed 
when the patients were taking inhaled corticosteroids. Our sub-
jects had taken inhaled corticosteroids for at least the previous 
3 months, to maintain optimal physical condition; therefore, 
corticosteroids might have caused an underestimation of air-
way dimensions in patients with severe asthma. Nevertheless, 
we believe that the relative influence of medication in our sub-
jects was minimal, because all subjects used corticosteroids at 
similar doses. Moreover, there are minimal data indicating that 
corticosteroid use influences airway remodeling,
42–45 and there 
is a theoretical advantage to evaluating the status of airway re-
modeling in stably maintained asthma. The use of post-bron-
chodilator FEV1/FVC as a marker of airway remodeling in our 
study may be criticized, because it has been not yet been con-
firmed to represent airway remodeling. In addition, this was a 
small study of 22 subjects, 86% of whom were female, which 
was not unexpected given that we excluded heavy smokers. The 
results of this study will need to be reproduced in different and 
larger patient populations. As another limitation, we were un-
able to apply multivariate regression analysis because of the 
small number of study subjects. However, we believe that the 
level of FEV1 reflected the impact of age and gender. In patients 
with stable asthma, radiation exposure may limit the clinical 
application of CT, and CT protocols with reduced radiation 
doses need to be developed further. Finally, AC might have 
been underestimated, because we measured the airway di-
mensions on suspended end-expiration and not dynamic expi-
ration. On suspended end-expiration, the airway may collapse 
less because the intrathoracic pressure is not maximal during Chae et al.
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dynamic expiration.
46 However, owing to motion artifacts and 
higher radiation dose, it is difficult to elicit the difference in air-
way dimensions in the segmental bronchi during dynamic ex-
piration.
In the present study, we demonstrated that post-bronchodila-
tor FEV1/FVC was significantly correlated with CT parameters, 
including WT%, WT, BA ratio, AC, and ATI. Our results support 
the theory that airway wall thickening associated with remodel-
ing causes a decrease in airway luminal collapsibility during ex-
piration in asthma. In conclusion, airway wall indices mea-
sured on inspiration and expiration CT, together with post-
bronchodilator FEV1/FVC, are useful indicators of the state of 
airway remodeling in stably managed patients with asthma.
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